Tuğrul Elverdi

9PUBLICATIONS
85CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 03, 2026
National Perspectives on Academic CAR-T Cell Therapy in Türkiye: A report from Turkish Society of Hematology, Scientific Subcommittee on Cell and Gene Therapies (TSH-CGT SSC).

|Jan 27, 2026
Salvage radiotherapy in refractory adult Hodgkin and non-Hodgkin lymphoma.

Muhammed Veysel Hekim, Şefika Arzu Ergen, Tuğrul Elverdi

|Jan 06, 2026
Navigating biosimilar transitions in IV rituximab therapy: Efficacy and safety insights from a real-world switching study.

Abdülkadir Erçalışkan, Duygu Seyhan Erdoğan, Furkan Bahar

|Jan 02, 2025
Amphotericin B Resistant Aspergillus spp.: Report of Two Cases.

Abdurrahman Kaya, Sibel Yıldız Kaya, İlker İnanç Balkan

|Jun 19, 2024
Is There an Immunohistochemical PD-L1 Cut-Off Point That Serves as a Prognostic Indicator for Large B-Cell Lymphomas?

Selcuk Cin, Suat Hilal Aki, Tugrul Elverdi

|Jun 03, 2022
Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

Murat Özbalak, Metban Güzel Mastanzade, Özden Özlük

Pageof 2

Frequent Collaborators

4 joint publications

Muhlis Cem Ar

3 joint publications

Ahmet Emre Eşkazan

2 joint publications

Sevgi Kalayoğlu Beşışık

2 joint publications

Meltem Kurt Yuksel